Aurinia Pharmaceuticals (AUPH) Times Interest Earned (2019 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Times Interest Earned came in at $40.93 in Q1 2026, up 15314.78% YoY from N/an in Q1 2025, and up 368.82% on a QoQ basis from -$15.23 in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Times Interest Earned (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 8 years of Times Interest Earned data on file, last reported at $40.93 in Q1 2026.
- Quarterly Times Interest Earned rose 15314.78% year-over-year to $40.93 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35.93 (down 9819.57% YoY) and the FY2025 annual result came in at $1.94, up 6493.57% from the prior year.
- Times Interest Earned advanced to $40.93 in Q1 2026, from -$15.23 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $40.93 in Q1 2026 to a low of -$248.77 in Q2 2023.
- A 5-year average of -$30.3 and a median of -$0.49 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned tumbled 23061.3% — and 2025, when it surged 16612.0%.
- Tracing AUPH's Times Interest Earned over 5 years: stood at -$23.42 in 2022, then tumbled by 329.57% to -$100.59 in 2023, then surged by 100.64% to $0.64 in 2024, then slumped by 2461.95% to -$15.23 in 2025, then surged by 368.82% to $40.93 in 2026.
- The last three Times Interest Earned figures came in at $40.93 (Q1 2026), -$15.23 (Q4 2025), and $4.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.69 |
| Mar 31, 2026 | 40.93 |
| Dec 31, 2025 | -15.23 |
| Sep 30, 2025 | 4.14 |
| Jun 30, 2025 | 2.69 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.64 |
| Sep 30, 2024 | 8.70 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -1.49 |
| Dec 31, 2023 | -100.59 |
| Sep 30, 2023 | -9.36 |
| Jun 30, 2023 | -248.77 |
| Mar 31, 2023 | -112.49 |
| Dec 31, 2022 | -23.42 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | 167.72 |
| Sep 30, 2021 | -0.60 |
| Jun 30, 2021 | -0.49 |
| Mar 31, 2021 | -4.34 |